Skip to main content

Table 4 Contingency tables and performance of the 14-3-3 test according to the initial clinical classification

From: Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD

  

Probable CJD, i n= 115

Possible CJD, i n= 73

non-sCJD, i n= 484

  

Initial diagnosis

Final diagnosis

sCJD f

non-sCJD f

sCJD f

non-sCJD f

sCJD f

non-sCJD f

14-3-3 result

Pos.

90 [36]

2

56 [27]

2

9 [4]

11

 

Neg.

17 [7]

6

5 [1]

10

0

464

Performance values (%)

      

PPV

97.8 (91.6–99.6)

96.5 (87.0–99.4)

45.0 (23.8–68.0)

NPV

26.1 (11.1–48.7)

66.6 (38.7–87.0)

100 (99.0–100.0)

Sensitivity

84.1 (75.5–90.2)

91.8 (81.2–96.9)

100 (62.9–100.0)

Specificity

75.0 (35.5–95.5)

83.3 (50.9–97.1)

97.7 (95.8–98.8)

Efficiency

83.5 (75.6–89.3)

90.4 (81.3–95.6)

97.7 (95.9–98.8)

Prevalence

93.0 (86.7–96.7)

83.6 (73.3–90.5)

1.9 (0.9–3.6)

  1. sCJDf includes both probable (WHO's criteria without the inclusion of the 14-3-3 test results) and definite cases at final diagnosis. Definite cases are shown in square brackets. Confidence intervals at 95% level are shown in parentheses.